QQQ   268.25 (-1.19%)
AAPL   447.31 (+0.64%)
MSFT   207.80 (-2.20%)
FB   263.54 (-1.83%)
GOOGL   1,488.98 (-0.63%)
AMZN   3,132.80 (-1.09%)
NVDA   445.25 (-0.61%)
CGC   18.14 (+9.08%)
BABA   247.17 (-1.96%)
TSLA   1,423.20 (-2.03%)
MU   48.99 (+0.49%)
GE   6.66 (+3.90%)
AMD   81.58 (-3.85%)
T   30.13 (+0.37%)
F   7.09 (+3.35%)
ACB   10.17 (-0.97%)
GILD   68.29 (-1.53%)
NFLX   484.82 (-2.00%)
DIS   129.55 (-0.29%)
BAC   26.66 (+2.11%)
BA   177.74 (+4.54%)
QQQ   268.25 (-1.19%)
AAPL   447.31 (+0.64%)
MSFT   207.80 (-2.20%)
FB   263.54 (-1.83%)
GOOGL   1,488.98 (-0.63%)
AMZN   3,132.80 (-1.09%)
NVDA   445.25 (-0.61%)
CGC   18.14 (+9.08%)
BABA   247.17 (-1.96%)
TSLA   1,423.20 (-2.03%)
MU   48.99 (+0.49%)
GE   6.66 (+3.90%)
AMD   81.58 (-3.85%)
T   30.13 (+0.37%)
F   7.09 (+3.35%)
ACB   10.17 (-0.97%)
GILD   68.29 (-1.53%)
NFLX   484.82 (-2.00%)
DIS   129.55 (-0.29%)
BAC   26.66 (+2.11%)
BA   177.74 (+4.54%)
QQQ   268.25 (-1.19%)
AAPL   447.31 (+0.64%)
MSFT   207.80 (-2.20%)
FB   263.54 (-1.83%)
GOOGL   1,488.98 (-0.63%)
AMZN   3,132.80 (-1.09%)
NVDA   445.25 (-0.61%)
CGC   18.14 (+9.08%)
BABA   247.17 (-1.96%)
TSLA   1,423.20 (-2.03%)
MU   48.99 (+0.49%)
GE   6.66 (+3.90%)
AMD   81.58 (-3.85%)
T   30.13 (+0.37%)
F   7.09 (+3.35%)
ACB   10.17 (-0.97%)
GILD   68.29 (-1.53%)
NFLX   484.82 (-2.00%)
DIS   129.55 (-0.29%)
BAC   26.66 (+2.11%)
BA   177.74 (+4.54%)
QQQ   268.25 (-1.19%)
AAPL   447.31 (+0.64%)
MSFT   207.80 (-2.20%)
FB   263.54 (-1.83%)
GOOGL   1,488.98 (-0.63%)
AMZN   3,132.80 (-1.09%)
NVDA   445.25 (-0.61%)
CGC   18.14 (+9.08%)
BABA   247.17 (-1.96%)
TSLA   1,423.20 (-2.03%)
MU   48.99 (+0.49%)
GE   6.66 (+3.90%)
AMD   81.58 (-3.85%)
T   30.13 (+0.37%)
F   7.09 (+3.35%)
ACB   10.17 (-0.97%)
GILD   68.29 (-1.53%)
NFLX   484.82 (-2.00%)
DIS   129.55 (-0.29%)
BAC   26.66 (+2.11%)
BA   177.74 (+4.54%)
Log in

NASDAQ:TENXTenax Therapeutics Stock Price, Forecast & News

$1.28
+0.03 (+2.40 %)
(As of 08/10/2020 12:01 PM ET)
Add
Compare
Today's Range
$1.28
Now: $1.28
$1.31
50-Day Range
$0.90
MA: $1.08
$1.39
52-Week Range
$0.25
Now: $1.28
$2.68
Volume1,100 shs
Average Volume493,283 shs
Market Capitalization$12.93 million
P/E RatioN/A
Dividend YieldN/A
Beta2.39
Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the identification, development, and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.18 out of 5 stars


Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TENX
CUSIPN/A
Phone919-855-2100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.56 per share

Profitability

Net Income$-8,390,000.00

Miscellaneous

Employees9
Market Cap$12.93 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable
$1.28
+0.03 (+2.40 %)
(As of 08/10/2020 12:01 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TENX News and Ratings via Email

Sign-up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tenax Therapeutics (NASDAQ:TENX) Frequently Asked Questions

How has Tenax Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

Tenax Therapeutics' stock was trading at $1.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, TENX shares have increased by 23.1% and is now trading at $1.28.
View which stocks have been most impacted by Coronavirus
.

When is Tenax Therapeutics' next earnings date?

Tenax Therapeutics is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020.
View our earnings forecast for Tenax Therapeutics
.

How were Tenax Therapeutics' earnings last quarter?

Tenax Therapeutics Inc (NASDAQ:TENX) released its earnings results on Friday, May, 15th. The specialty pharmaceutical company reported ($0.38) earnings per share for the quarter.
View Tenax Therapeutics' earnings history
.

When did Tenax Therapeutics' stock split? How did Tenax Therapeutics' stock split work?

Tenax Therapeutics's stock reverse split on Monday, February 26th 2018. The 1-20 reverse split was announced on Friday, February 23rd 2018. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 23rd 2018. An investor that had 100 shares of Tenax Therapeutics stock prior to the reverse split would have 5 shares after the split.

Has Tenax Therapeutics been receiving favorable news coverage?

News stories about TENX stock have been trending very positive recently, InfoTrie reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Tenax Therapeutics earned a news impact score of 3.2 on InfoTrie's scale. They also assigned news articles about the specialty pharmaceutical company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future.
View the latest news about Tenax Therapeutics
.

Who are some of Tenax Therapeutics' key competitors?

What other stocks do shareholders of Tenax Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tenax Therapeutics investors own include Inovio Pharmaceuticals (INO), AcelRx Pharmaceuticals (ACRX), Bank of Hawaii (BOH), Idera Pharmaceuticals (IDRA), Gilead Sciences (GILD), InterDigital Wireless (IDCC), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE), Novavax (NVAX) and Verastem (VSTM).

Who are Tenax Therapeutics' key executives?

Tenax Therapeutics' management team includes the following people:
  • Mr. Anthony A. DiTonno, CEO & Director (Age 71)
  • Mr. Michael B. Jebsen, Pres & CFO (Age 48)
  • Ms. Nancy J. M. Hecox, Exec. VP of Legal Affairs, Gen. Counsel & Corp. Sec.
  • Maria Isabel Tomargo, Assistant VP of Marketing & Sales
  • Mr. Robert F. Diegelmann, Head of New Wound Care Division

What is Tenax Therapeutics' stock symbol?

Tenax Therapeutics trades on the NASDAQ under the ticker symbol "TENX."

Who are Tenax Therapeutics' major shareholders?

Tenax Therapeutics' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Wedbush Securities Inc. (0.52%) and Virtu Financial LLC (0.45%).
View institutional ownership trends for Tenax Therapeutics
.

Which institutional investors are buying Tenax Therapeutics stock?

TENX stock was purchased by a variety of institutional investors in the last quarter, including Wedbush Securities Inc., and Virtu Financial LLC.
View insider buying and selling activity for Tenax Therapeutics
.

How do I buy shares of Tenax Therapeutics?

Shares of TENX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tenax Therapeutics' stock price today?

One share of TENX stock can currently be purchased for approximately $1.28.

How big of a company is Tenax Therapeutics?

Tenax Therapeutics has a market capitalization of $12.93 million. Tenax Therapeutics employs 9 workers across the globe.

What is Tenax Therapeutics' official website?

The official website for Tenax Therapeutics is www.tenaxthera.com.

How can I contact Tenax Therapeutics?

Tenax Therapeutics' mailing address is ONE COPLEY PARKWAY SUITE 490, MORRISVILLE NC, 27560. The specialty pharmaceutical company can be reached via phone at 919-855-2100 or via email at [email protected]

This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.